Clinical Trial

Studying Heart Ablation After Left Atrial Closure in High-Bleeding-Risk Atrial Fibrillation Patients

Study acronym: PROCEED-AF
Completed
View on ClinicalTrials.gov →
Summary
The purpose of this multicenter study is to collect information from routine clinical practices for patients with left atrial appendage occlusion (LAAO) devices presenting for pulmonary vein isolation (PVI) or left atrial ablation. Assessment will include characterization of patient characteristics, procedural details, management of post-procedure anticoagulation, and clinical outcomes.
Trial Details
NCT Number NCT07580937
Lead Sponsor University of Chicago
Collaborators: Rush University
Conditions Atrial Fibrillation, Atrial Arrhythmia
Enrollment 198 participants
Start Date 2022-03-08
Primary Completion 2024-12-10 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-12